<DOC>
	<DOCNO>NCT00307970</DOCNO>
	<brief_summary>To compare lung delivery fluticasone propionate deliver HFA-pMDI , use conventional polycarbonate anti-static chamber/mask randomize crossover design 1-6 year old child . Hypothesis : Anti-static chamber/mask would increase amount inhaled corticosteroid deliver young child passively inhale breath hold .</brief_summary>
	<brief_title>Impact Anti-static Chamber/Mask</brief_title>
	<detailed_description>Objective -- determine whether anti-static chamber increase one-hour steady-state fluticasone plasma concentration , indirect measure airway delivery direct measure systemic exposure . Twelve child 1-6 yrs well-controlled persistent asthma treat HFA-FP pMDI , 2 actuation 110 Âµg twice daily . The drug administer conventional polycarbonate anti-static valved-holding chamber mask unblinded , randomize , crossover manner least three day . A blood sample collect one hour last dose adherence document electronic monitor 100 % . FP plasma concentration measure liquid chromatography mass spectrometry assay . Results evaluate use regression analysis .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>child 16 year old ; adequately control persistent asthma ; currently receive FP deliver CFC MDI attach valvedholding chamber/mask ; ability use chamber mask effectively inadequately control asthma : nocturnal awaken &gt; 2 nights/month , prn albuterol use &gt; 2x/week , 2 short course oral corticosteroid previous 3 month , miss dose one occasion , increase asthma symptom study , inability discontinue intranasal dermal fluticasone 3 day</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>June 2004</verification_date>
	<keyword>fluticasone</keyword>
	<keyword>asthma therapy</keyword>
	<keyword>spacer inhaler</keyword>
	<keyword>HFA-134a</keyword>
</DOC>